InvestingNewsNewsTrending Stocks

$FWBI First Wave BioPharma Stock In Play Ahead Of Imminent Trial Data Release

First Wave BioPharma, Inc., (NASDAQ: $FWBI) will be in focus next week, with James Sapirstein, Chairman and Chief Executive Officer, delivering a virtual presentation at Maxim’s 2022 Virtual Growth Conference being held March 28 – 30, 2022.

It’s a prerecorded presentation and the impact could be significant. After all, for those following $FWBI, they should have a lot to say. See our L3T coverage HERE.

$FWBI noted that the presentation will become available on-demand to all registered conference attendees. Mr. Sapirstein will provide an overview of First Wave BioPharma’s business and clinical development programs, and highlight recent corporate achievements, as well as anticipated milestones. Members of the company’s management team will be available for one-on-one virtual meetings.

Details of the conference are as follows:

Event: Maxim’s 2022 Virtual Growth Conference
Date: March 28-30, 2022
Registration: https://m-vest.com/events/2022-virtual-growth-conference

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button